http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105878196-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7390d83907b6a5043c4aa685e25c77ff
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfcc8216d1a8178e206bfff470ff4960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bda43f6a4b57cdf5250aed15c3b8a4dc
publicationDate 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105878196-A
titleOfInvention Atorvastatin calcium tablet and preparation method thereof
abstract The invention relates to an atorvastatin calcium tablet and a preparation method thereof. The tablet belongs to the technical field of Western medicines, wherein the weight ratio of atorvastatin calcium to a filling agent to a disintegrating agent to a lubricating agent is at 1 to (9-14) to (1-2) to (0.3-0.4). The tablet disclosed by the invention is stable in quality, rapid in disintegration and dissolution, high in bioavailability, moderate in hardness and simple in preparation process.
priorityDate 2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448850249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448257843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227

Total number of triples: 41.